A detailed history of Alliancebernstein L.P. transactions in Liva Nova PLC stock. As of the latest transaction made, Alliancebernstein L.P. holds 113,650 shares of LIVN stock, worth $5.68 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
113,650
Previous 115,419 1.53%
Holding current value
$5.68 Million
Previous $6.33 Million 5.69%
% of portfolio
0.0%
Previous 0.0%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$43.38 - $54.59 $76,739 - $96,569
-1,769 Reduced 1.53%
113,650 $5.97 Million
Q2 2024

Aug 14, 2024

SELL
$51.76 - $64.15 $21.2 Million - $26.3 Million
-410,383 Reduced 78.05%
115,419 $6.33 Million
Q1 2024

May 14, 2024

SELL
$48.6 - $57.12 $49.5 Million - $58.1 Million
-1,017,826 Reduced 65.94%
525,802 $29.4 Million
Q4 2023

Feb 14, 2024

BUY
$43.45 - $53.66 $1.93 Million - $2.39 Million
44,514 Added 2.97%
1,543,628 $79.9 Million
Q3 2023

Nov 14, 2023

SELL
$50.12 - $58.87 $36.4 Million - $42.8 Million
-726,249 Reduced 32.64%
1,499,114 $79.3 Million
Q2 2023

Aug 15, 2023

BUY
$42.28 - $51.43 $55.4 Million - $67.3 Million
1,309,486 Added 142.98%
2,225,363 $114 Million
Q1 2023

May 15, 2023

BUY
$40.84 - $58.14 $8.82 Million - $12.6 Million
215,960 Added 30.86%
915,877 $39.9 Million
Q4 2022

Feb 14, 2023

BUY
$43.88 - $56.16 $299,349 - $383,123
6,822 Added 0.98%
699,917 $38.9 Million
Q3 2022

Nov 15, 2022

BUY
$48.37 - $66.5 $1.16 Million - $1.59 Million
23,980 Added 3.58%
693,095 $35.2 Million
Q2 2022

Aug 15, 2022

BUY
$57.25 - $86.63 $55,761 - $84,377
974 Added 0.15%
669,115 $41.8 Million
Q1 2022

May 13, 2022

SELL
$71.02 - $86.99 $1.18 Million - $1.45 Million
-16,638 Reduced 2.43%
668,141 $54.7 Million
Q4 2021

Feb 14, 2022

SELL
$76.72 - $92.68 $8,976 - $10,843
-117 Reduced 0.02%
684,779 $59.9 Million
Q3 2021

Nov 10, 2021

BUY
$76.02 - $88.62 $855,225 - $996,975
11,250 Added 1.67%
684,896 $54.2 Million
Q2 2021

Jul 30, 2021

SELL
$73.44 - $87.01 $388,864 - $460,717
-5,295 Reduced 0.78%
673,646 $56.7 Million
Q1 2021

May 06, 2021

SELL
$62.9 - $82.41 $15.4 Million - $20.2 Million
-245,040 Reduced 26.52%
678,941 $50.1 Million
Q4 2020

Feb 08, 2021

BUY
$46.01 - $68.74 $36.6 Million - $54.8 Million
796,556 Added 625.12%
923,981 $61.2 Million
Q3 2020

Nov 12, 2020

SELL
$41.91 - $57.81 $96,392 - $132,963
-2,300 Reduced 1.77%
127,425 $5.76 Million
Q2 2020

Aug 13, 2020

BUY
$39.87 - $56.9 $61,798 - $88,195
1,550 Added 1.21%
129,725 $6.24 Million
Q1 2020

May 14, 2020

SELL
$34.22 - $76.49 $11,634 - $26,006
-340 Reduced 0.26%
128,175 $5.8 Million
Q4 2019

Feb 18, 2020

SELL
$68.92 - $85.27 $1.42 Million - $1.76 Million
-20,630 Reduced 13.83%
128,515 $9.69 Million
Q3 2019

Nov 14, 2019

SELL
$71.74 - $86.35 $508,636 - $612,221
-7,090 Reduced 4.54%
149,145 $11 Million
Q2 2019

Aug 14, 2019

SELL
$66.45 - $97.36 $1.08 Million - $1.58 Million
-16,250 Reduced 9.42%
156,235 $11.2 Million
Q1 2019

May 14, 2019

SELL
$86.15 - $100.49 $90,802 - $105,916
-1,054 Reduced 0.61%
172,485 $16.8 Million
Q4 2018

Feb 13, 2019

BUY
$84.14 - $125.42 $2.37 Million - $3.53 Million
28,110 Added 19.33%
173,539 $15.9 Million
Q3 2018

Nov 08, 2018

BUY
$101.02 - $130.95 $5.2 Million - $6.74 Million
51,475 Added 54.79%
145,429 $18 Million
Q2 2018

Aug 13, 2018

BUY
$81.75 - $105.37 $660,540 - $851,389
8,080 Added 9.41%
93,954 $9.38 Million
Q1 2018

May 14, 2018

BUY
$79.95 - $89.74 $1.18 Million - $1.33 Million
14,800 Added 20.82%
85,874 $7.6 Million
Q4 2017

Feb 13, 2018

SELL
$71.8 - $88.21 $2,154 - $2,646
-30 Reduced 0.04%
71,074 $5.68 Million
Q3 2017

Nov 13, 2017

BUY
$60.32 - $70.06 $4.29 Million - $4.98 Million
71,104
71,104 $4.98 Million

Others Institutions Holding LIVN

About LivaNova PLC


  • Ticker LIVN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 53,545,700
  • Market Cap $2.67B
  • Description
  • LivaNova PLC, a medical device company, designs, develops, manufactures, and sells therapeutic solutions worldwide. It operates through three segments: Cardiopulmonary, Neuromodulation, and Advanced Circulatory Support. The Cardiopulmonary segment develops, produces, and sells cardiopulmonary products, including oxygenators, heart-lung machines,...
More about LIVN
Track This Portfolio

Track Alliancebernstein L.P. Portfolio

Follow Alliancebernstein L.P. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Alliancebernstein L.P., based on Form 13F filings with the SEC.

News

Stay updated on Alliancebernstein L.P. with notifications on news.